MedPath

Investigating the effect of platelet rich plasma (PRP) injection in women with stress urinary incontinence

Phase 3
Conditions
Other specified urinary incontinence
N39.49
Stress urinary incontinence.
Registration Number
IRCT20221208056749N1
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
60
Inclusion Criteria

Women over 20 years
Moderate to mild stress urinary incontinence
Diagnosing stress urinary incontinence based on history, physical examination and questionnaire
Failure to respond to medical treatments for stress urinary incontinence
Written informed consent to participate in the present study

Exclusion Criteria

Existence of detrusor hyperactivity in urodynamics
History of stress urinary incontinence surgery
Urinary tract infection
Obesity (BMI greater than 30)

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain. Timepoint: One month, 3 months, 6 months and 12 months after surgery. Method of measurement: Visual Analogue Scale.;Amount of urine leakage. Timepoint: One month, 3 months, 6 months and 12 months after surgery. Method of measurement: Urinary distress inventory (UDI-6).;Frequency of urinary leakage. Timepoint: One month, 3 months, 6 months and 12 months after surgery. Method of measurement: Incontinence Questionnaire–Urinary Incontinence Short Form (ICIQ-UI SF).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath